A Phase II international, multicenter study of oral panobinostat (LBH589) in patients with refractory cutaneous T-cell lymphoma Conference

cited authors

  • Bernengo, MG; Vanaclocha, F; Duvic, M; Kuzel, T; Kerdel, F; Pinter-Brown, L; Bosly, A; Okada, C; Breneman, D; Zinzani, PL; Becker, J; Hughey, L; Ardaiz, M; Zain, J; Zhang, L; Hirawat, S; Laird, G; Johnson, D; Prince, HM

fiu authors

publication date

  • October 27, 2008

start page

  • 44

end page

  • 45


  • 2


  • 5